Skip to main content
Clinical Trials/CTRI/2023/05/052826
CTRI/2023/05/052826
Not yet recruiting
Phase 2

RANDOMIZED CONTROLLED CLINICAL TRIAL TO COMPARE THE EFFICACY OF MANJISHTHADI TAILAM & MANJISHTHADI CREAM WITH HYDROQUINONE 2% CREAM IN THE MANAGEMENT OF VYANGA (MELASMA).

ilam Pravin Chavan0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: L819- Disorder of pigmentation, unspecified
Sponsor
ilam Pravin Chavan
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
ilam Pravin Chavan

Eligibility Criteria

Inclusion Criteria

  • Patients having Age between 20\-60 years of any gender.
  • Patients having cardinal symptoms of vyanga like niruja , tanu , shyava
  • mandal over face , chronicity less than 5 years.
  • All the three clinical presentations that is 1\)
  • Central facial pattern 2\) Malar
  • Pattern 3\)Mandibular Pattern. Will be included in the study.
  • Patients who are willing to participate in the study.

Exclusion Criteria

  • Hyperpigmentation caused due to any systemic illness such as Addisonâ??s
  • disease , systemic lupus erythematous.
  • Hyperpigmentation caused by malignant melanoma.
  • Pregnant and lactating females.
  • Patients having congenital hyperpigmentation like nevus.

Outcomes

Primary Outcomes

Not specified

Similar Trials